海思科最新公告:获得创新药HSK55879片临床试验批准通知书

中金财经
Mar 15

  海思科(002653.SZ)公告称,子公司上海海思盛诺医药科技有限公司近日收到国家药品监督管理局下发的《药物临床试验批准通知书》,同意HSK55879片开展两个适应症的临床试验。为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10